Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Second malignant neoplasms following hematopoietic stem cell transplantation.

Friedman DL, Leisenring W, Schwartz JL, Deeg HJ.

Int J Hematol. 2004 Apr;79(3):229-34. Review.

PMID:
15168589
[PubMed - indexed for MEDLINE]
2.

Secondary malignancies after hematopoietic stem cell transplantation.

Roziakova L, Bojtarova E, Mistrik M, Mladosievicova B.

Neoplasma. 2011;58(1):1-8. Review.

PMID:
21067259
[PubMed - indexed for MEDLINE]
3.

Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems.

Adès L, Guardiola P, Sociè G.

Blood Rev. 2002 Jun;16(2):135-46. Review.

PMID:
12127957
[PubMed - indexed for MEDLINE]
4.

Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma.

Tward J, Glenn M, Pulsipher M, Barnette P, Gaffney D.

Leuk Lymphoma. 2007 Aug;48(8):1482-95. Review.

PMID:
17701578
[PubMed - indexed for MEDLINE]
5.

High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.

Forrest DL, Hogge DE, Nevill TJ, Nantel SH, Barnett MJ, Shepherd JD, Sutherland HJ, Toze CL, Smith CA, Lavoie JC, Song KW, Voss NJ, Gascoyne RD, Connors JM.

J Clin Oncol. 2005 Nov 1;23(31):7994-8002. Epub 2005 Oct 3.

PMID:
16204014
[PubMed - indexed for MEDLINE]
6.

Stem cell transplantation: supportive care and long-term complications.

Wingard JR, Vogelsang GB, Deeg HJ.

Hematology Am Soc Hematol Educ Program. 2002:422-44. Review.

PMID:
12446435
[PubMed - indexed for MEDLINE]
Free Article
7.

Late complications in blood and marrow transplant survivors.

Majhail NS.

Minn Med. 2010 Oct;93(10):45-9.

PMID:
21140762
[PubMed - indexed for MEDLINE]
8.

Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.

Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socié G.

J Clin Oncol. 2007 Jun 10;25(17):2449-54.

PMID:
17557958
[PubMed - indexed for MEDLINE]
9.

Secondary malignancies after hematopoietic stem cell transplantation.

Ghelani D, Saliba R, Lima Md.

Crit Rev Oncol Hematol. 2005 Oct;56(1):115-26. Review.

PMID:
15979325
[PubMed - indexed for MEDLINE]
10.

Second malignancies after allogeneic hematopoietic cell transplantation.

Lowe T, Bhatia S, Somlo G.

Biol Blood Marrow Transplant. 2007 Oct;13(10):1121-34. Review.

PMID:
17889348
[PubMed - indexed for MEDLINE]
11.

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G; EBMT Late Effects Working Party.

Haematologica. 2008 Aug;93(8):1203-10. doi: 10.3324/haematol.12949. Epub 2008 Jun 12.

PMID:
18556401
[PubMed - indexed for MEDLINE]
Free Article
12.

Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

Seshadri T, Pintilie M, Kuruvilla J, Keating A, Tsang R, Zadeh S, Crump M.

Leuk Lymphoma. 2009 Mar;50(3):380-6. doi: 10.1080/10428190902756578.

PMID:
19347727
[PubMed - indexed for MEDLINE]
13.

Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation.

Hsieh MM, Fitzhugh CD, Tisdale JF.

Blood. 2009 Jul 2;114(1):225; author reply 225-6. doi: 10.1182/blood-2009-03-209015. No abstract available.

PMID:
19574484
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Oral malignancies following HSCT: graft versus host disease and other risk factors.

Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A.

Oral Oncol. 2005 Oct;41(9):865-77. Epub 2005 Apr 14. Review.

PMID:
16084755
[PubMed - indexed for MEDLINE]
15.

Second solid cancers after allogeneic hematopoietic stem cell transplantation.

Gallagher G, Forrest DL.

Cancer. 2007 Jan 1;109(1):84-92.

PMID:
17131350
[PubMed - indexed for MEDLINE]
Free Article
16.

Donor-derived solid malignancies after hematopoietic stem cell transplantation.

Hu YX, Cui Q, Liang B, Huang H.

Onkologie. 2010;33(4):195-200. doi: 10.1159/000290661. Epub 2010 Mar 19. Review.

PMID:
20389147
[PubMed - indexed for MEDLINE]
17.

The sources and uses of hematopoietic stem cells keep increasing.

Trigg ME.

Del Med J. 1998 Sep;70(9):387-92.

PMID:
9805406
[PubMed - indexed for MEDLINE]
18.

Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies.

Ricardi U, Filippi AR, Biasin E, Ciammella P, Botticella A, Franco P, Corrias A, Vassallo E, Ragona R, Fagioli F.

Strahlenther Onkol. 2009 Aug;185 Suppl 2:17-20. doi: 10.1007/s00066-009-1008-x. No abstract available.

PMID:
19685029
[PubMed - indexed for MEDLINE]
19.

Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.

Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, Taji H, Kitaori K, Goto S, Iida H, Morishima Y, Kodera Y, Naoe T, Morishita Y.

Bone Marrow Transplant. 2005 Jul;36(2):115-21.

PMID:
15908969
[PubMed - indexed for MEDLINE]
20.

Old and new cancers after hematopoietic-cell transplantation.

Majhail NS.

Hematology Am Soc Hematol Educ Program. 2008:142-9. doi: 10.1182/asheducation-2008.1.142.

PMID:
19074072
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk